Compare ImmunityBio Inc. Common Stock (IBRX) vs Roku Inc. Class A Common Stock (ROKU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Roku Inc. Class A Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.49 (market cap $10.51B), while Roku Inc. Class A Common Stock trades at $152.81 (market cap $22.84B). The key difference: Roku Inc. Class A Common Stock is far larger — about 2.2× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 1,030,322). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 1 Days and Roku Inc. Class A Common Stock for 1 Days on average.
| IBRX | ROKU | |
|---|---|---|
Market Cap | $10.51B | $22.84B |
Volume | 10,445,785 | 1,030,322 |
Sector | Health | Media |
52-Week High | $11.55 | $159.76 |
52-Week Low | $1.98 | $82.93 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $10.97B | $20.76B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Roku Inc. Class A Common Stock
Roku operates a streaming platform that combines its operating system, streaming devices, TV partnerships, and advertising services. It connects viewers with streaming content and services.
Read more on ROKU →
